Calcium channel blocker: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Drug List/ja}} | {{Drug List/ja}} | ||
{{Pathnav|Medication/ja|Antihypertensive drug/ja}} | {{Pathnav|Medication/ja|Antihypertensive drug/ja|frame=1}} | ||
{| class="wikitable sortable" style="width:100%" | |||
|+[[Dihydropyridine/ja|ジヒドロビリジン系]] | |||
|- | |||
!一般名 | |||
!先発名 | |||
!class="unsortable"| 日本 | |||
!開発 | |||
!備考 | |||
|- | |||
|[[Amlodipine/ja]] | |||
|ノルバスク(Norvasc) ([https://pins.japic.or.jp/pdf/newPINS/00058792.pdf PI]) ([https://www.viatris-e-channel.com/viatris-products/di/pdf/nor01if.pdf IF]) | |||
|○ | |||
|[[Pfizer]] | |||
| | |||
|- | |||
|[[Aranidipine/ja]] | |||
|サプレスタ(Sapresta) ([https://s3-ap-northeast-1.amazonaws.com/medley-medicine/prescriptionpdf/400107_2149038D1044_1_04.pdf PI] [https://image.packageinsert.jp/pdf.php?mode=1&yjcode=2149038D1044 IF]) | |||
| | |||
|[[:ja:日医工|マルコ製薬]]<br />[[:ja:大鵬薬品工業|大鵬薬品]] | |||
| | |||
|- | |||
|} | |||
<languages /> | <languages /> | ||
<translate> | <translate> | ||